Sunpharmacy
Sun Pharmaceutical Industries' key products/revenue segments include Pharmaceuticals which contributed Rs 9783.29 crore to sales value (94.95 percent of total sales) and Other Operating Revenue which contributed Rs 519.92 crore to sales value (5.04 percent of total sales)for the year ending March 31, 2019. It is going bullish with a stop loss of 390 rs and takes profit at 450 rs.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.